Vascular function and endothelin-1: Tipping the balance between vasodilation and vasoconstriction

Journal of Applied Physiology

Volumn 122, Issue 2, 2017, Pages 354-360

  Nishiyama, Steven K ^a   Zhao, Jia ^b   Wray, D Walter ^b,c,d   Richardson, Russell S ^b,c,d  

^a TOURO UNIVERSITY NEVADA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Endothelium; Flow mediated dilation; Vascular function

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; VASOCONSTRICTOR AGENT;

ADULT; BLOOD FLOW; DRUG EFFECTS; EXERCISE; FEMALE; HUMAN; HYPEREMIA; INTRAARTERIAL DRUG ADMINISTRATION; LEG; MALE; METABOLISM; PHYSIOLOGY; POPLITEAL ARTERY; PROCEDURES; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION; YOUNG ADULT;

ADULT; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EXERCISE; FEMALE; HUMANS; HYPEREMIA; INFUSIONS, INTRA-ARTERIAL; LEG; MALE; NITRIC OXIDE; POPLITEAL ARTERY; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; YOUNG ADULT;

EID: 85014830948     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00772.2016     Document Type: Article

References (67)

1. Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, Schiffrin EL. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110: 2233-2240, 2004. doi:10.1161/01.CIR. 0000144462.08345.B9
2. Barden J, Lawrenson L, Poole JG, Kim J, Wray DW, Bailey DM, Richardson RS. Limitations to vasodilatory capacity and. VO2 max in trained human skeletal muscle. Am J Physiol Heart Circ Physiol 292: H2491-H2497, 2007. doi:10.1152/ajpheart.01396.2006
3. Barrett-O'Keefe Z, Ives SJ, Trinity JD, Morgan G, Rossman MJ, Donato AJ, Runnels S, Morgan DE, Gmelch BS, Bledsoe AD, Richardson RS, Wray DW. Endothelin-A-mediated vasoconstriction during exercise with advancing age. J Gerontol A Biol Sci Med Sci 70: 554-556, 2015. doi:10.1093/gerona/glu065
4. Barrett-O'Keefe Z, Ives SJ, Trinity JD, Morgan G, Rossman MJ, Donato AJ, Runnels S, Morgan DE, Gmelch BS, Bledsoe AD, Richardson RS, Wray DW. Taming the "sleeping giant": the role of endothelin-1 in the regulation of skeletal muscle blood flow and arterial blood pressure during exercise. Am J Physiol Heart Circ Physiol 304: H162-H169, 2013. doi:10.1152/ajpheart.00603.2012
5. Barton M, d'Uscio LV, Shaw S, Meyer P, Moreau P, Lüscher TF. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension 31: 499-504, 1998. doi:10.1161/01.HYP.31.1.499
6. Berger R, Stanek B, Hülsmann M, Frey B, Heher S, Pacher R, Neunteufl T. Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure. Circulation 103: 981-986, 2001. doi:10.1161/01.CIR.103.7.981
7. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension 51: 203-210, 2008. doi:10.1161/HYPERTENSIONAHA.107.101014
8. Böhm F, Ahlborg G, Pernow J. Endothelin-1 inhibits endotheliumdependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin Sci (Lond) 102: 321-327, 2002. doi:10.1042/cs1020321
9. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000. doi:10.1161/01. RES.87.10.840
10. Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 105: 452-456, 2002. doi:10.1161/hc0402.102989
11. Cardillo C, Kilcoyne CM, Cannon RO III, Panza JA. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 35: 1237-1241, 2000. doi:10.1161/01.HYP.35.6.1237
12. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon RO III, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 33: 753-758, 1999. doi:10.1161/01.HYP.33.2.753
13. Casey DP, Nichols WW, Conti CR, Braith RW. Relationship between endogenous concentrations of vasoactive substances and measures of peripheral vasodilator function in patients with coronary artery disease. Clin Exp Pharmacol Physiol 37: 24-28, 2010
14. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24: 471-476, 1994. doi:10.1016/0735-1097(94)90305-0
15. Clarke JG, Larkin SW, Benjamin N, Keogh BE, Chester A, Davies GJ, Taylor KM, Maseri A. Endothelin-1 is a potent long-lasting vasoconstrictor in dog peripheral vasculature in vivo. J Cardiovasc Pharmacol 13, Suppl 5: S211-S212, 1989. doi:10.1097/00005344-198900135-00061
16. Cockcroft JR, Clarke JG, Webb DJ. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man. Br J Clin Pharmacol 31: 521-524, 1991. doi:10.1111/j.1365-2125.1991.tb05573.x
17. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48: 489-509, 1997. doi:10.1146/annurev.med.48.1. 489
18. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265, 2002. doi:10.1016/S0735-1097(01)01746-6
19. de Groot PC, Poelkens F, Kooijman M, Hopman MT. Preserved flow-mediated dilation in the inactive legs of spinal cord-injured individuals. Am J Physiol Heart Circ Physiol 287: H374-H380, 2004. doi:10. 1152/ajpheart.00958.2003
20. Deng LY, Li JS, Schiffrin EL. Endothelin receptor subtypes in resistance arteries from humans and rats. Cardiovasc Res 29: 532-535, 1995. doi:10.1016/S0008-6363(96)88530-0
21. Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K, Seals DR. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 297: H425-H432, 2009. doi:10.1152/ajpheart.00689.2008
22. Dyson KS, Shoemaker JK, Hughson RL. Effect of acute sympathetic nervous system activation on flow-mediated dilation of brachial artery. Am J Physiol Heart Circ Physiol 290: H1446-H1453, 2006. doi:10.1152/ajpheart.00771.2005
23. Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5: 4, 2006. doi:10.1186/1475-2840-5-4
24. Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 145: 943-951, 2003. doi:10.1016/S0002-8703(03)00097-8
25. Gokce N. Clinical Manifestations of Endothelial Dysfunction. Philadelphia, PA: Lippincott Williams & Wilkins, 2002, p. 685-706
26. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-mediated dilation. Hypertension 55: 1075-1085, 2010. doi:10.1161/HYPERTENSIONAHA.110.150821
27. Harris RA, Nishiyama SK, Wray DW, Tedjasaputra V, Bailey DM, Richardson RS. The effect of oral antioxidants on brachial artery flowmediated dilation following 5 and 10 min of ischemia. Eur J Appl Physiol 107: 445-453, 2009. doi:10.1007/s00421-009-1147-x
28. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascularresistance and blood pressure in humans. Circulation 93: 1860-1870, 1996. doi:10.1161/01.CIR.93.10.1860
29. Haynes WG, Strachan FE, Webb DJ. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92: 357-363, 1995. doi:10.1161/01.CIR.92.3.357
30. Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 16: 1081-1098, 1998. doi:10. 1097/00004872-199816080-00001
31. Haynes WG, Webb DJ. Endothelin: a long-acting local constrictor hormone. Br J Hosp Med 47: 340-349, 1992
32. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endotheliumdependent, flow-mediated vasodilation. J Am Coll Cardiol 39: 683-688, 2002. doi:10.1016/S0735-1097(01)01786-7
33. Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, Shpilman A, Menzoian JO, Watkins MT, Raffetto JD, Gibbons G, Woodson J, Shaw PM, Dhadly M, Eberhardt RT, Keaney JF Jr, Gokce N, Vita JA. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 27: 2113-2119, 2007. doi:10. 1161/ATVBAHA.107.147322
34. Iglarz M, Clozel M. Mechanisms of ET-1-induced endothelial dysfunction. J Cardiovasc Pharmacol 50: 621-628, 2007. doi:10.1097/FJC. 0b013e31813c6cc3
35. Just A, Olson AJ, Arendshorst WJ. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors. Am J Physiol Renal Physiol 286: F660-F668, 2004. doi:10.1152/ajprenal.00368.2003
36. Karaa A, Kamoun WS, Clemens MG. Oxidative stress disrupts nitric oxide synthase activation in liver endothelial cells. Free Radic Biol Med 39: 1320-1331, 2005. doi:10.1016/j.freeradbiomed.2005.06.014
37. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88: 1054-1057, 1991. doi:10.1172/JCI115367
38. Krum H, Cranswick N, Pellizzer AM. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man. Clin Sci (Lond) 95: 151-156, 1998. doi:10.1042/cs0950151
39. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997-1001, 1991. doi:10. 1056/NEJM199110033251404
40. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 332: 512-521, 1995. doi:10.1056/NEJM199502233320807
41. Lüscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102: 2434-2440, 2000. doi:10.1161/01.CIR.102.19.2434
42. Macarthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 200: 395-400, 1994. doi:10.1006/bbrc.1994.1462
43. Malek A, Izumo S. Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am J PhysioCell Physiol 263: C389-C396, 1992
44. Mancini GB, Yeoh E, Abbott D, Chan S. Validation of an automated method for assessing brachial artery endothelial dysfunction. Can J Cardiol 18: 259-262, 2002
45. Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59: 745-754, 2003. doi:10.1016/S0008-6363(03)00479-6
46. Nishiyama SK, Walter Wray D, Berkstresser K, Ramaswamy M, Richardson RS. Limb-specific differences in flow-mediated dilation: the role of shear rate. J Appl Physiol (1985) 103: 843-851, 2007. doi:10.1152/japplphysiol.00273.2007
47. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990. doi:10.1056/NEJM199007053230105
48. Parker BA, Smithmyer SL, Jarvis SS, Ridout SJ, Pawelczyk JA, Proctor DN. Evidence for reduced sympatholysis in leg resistance vasculature of healthy older women. Am J Physiol Heart Circ Physiol 292: H1148-H1156, 2007. doi:10.1152/ajpheart.00729.2006
49. Parker BA, Trehearn TL, Meendering JR. Pick your Poiseuille: normalizing the shear stimulus in studies of flow-mediated dilation. J Appl Physiol (1985) 107: 1357-1359, 2009. doi:10.1152/japplphysiol.91302.2008
50. Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4: 71-95, 2009. doi:10.1146/annurev. pathol.4.110807.092155
51. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37-44, 1986. doi:10.1161/01.HYP.8.1.37
52. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 568: 357-369, 2005. doi:10.1113/jphysiol.2005.089755
53. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 314: 488-500, 1986. doi:10.1056/NEJM198602203140806
54. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990. doi:10. 1038/348732a0
55. Spieker LE, Flammer AJ, Lüscher TF. The vascular endothelium in hypertension. Handb Exp Pharmacol 176: 249-283, 2006. doi:10.1007/3-540-36028-X-8
56. Spieker LE, Hürlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S, Hayoz D, Deanfield JE, Lüscher TF, Noll G. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 105: 2817-2820, 2002. doi:10.1161/01.CIR.0000021598.15895.34
57. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 85: 510-517, 1992. doi:10.1161/01.CIR.85.2.510
58. Strachan FE, Newby DE, Sciberras DG, McCrea JB, Goldberg MR, Webb DJ. Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography. Br J Clin Pharmacol 54: 386-394, 2002. doi:10.1046/j.1365-2125.2002.01653.x
59. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 82: 1535-1539, 1998. doi:10.1016/S0002-9149(98)00702-4
60. Thijssen DH, Atkinson CL, Ono K, Sprung VS, Spence AL, Pugh CJ, Green DJ. Sympathetic nervous system activation, arterial shear rate, and flow-mediated dilation. J Appl Physiol (1985) 116: 1300-1307, 2014. doi:10.1152/japplphysiol.00110.2014
61. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300: H2-H12, 2011. doi:10. 1152/ajpheart.00471.2010
62. Thijssen DH, Rongen GA, Smits P, Hopman MT. Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations. J Physiol 586: 319-324, 2008. doi:10.1113/jphysiol.2007.145698
63. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97: 752-756, 1998. doi:10. 1161/01.CIR.97.8.752
64. Wray DW, Nishiyama SK, Donato AJ, Sander M, Wagner PD, Richardson RS. Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans. Am J Physiol Heart Circ Physiol 293: H2550-H2556, 2007. doi:10.1152/ajpheart.00867.2007
65. Wray DW, Uberoi A, Lawrenson L, Richardson RS. Evidence of preserved endothelial function and vascular plasticity with age. Am J Physiol Heart Circ Physiol 290: H1271-H1277, 2006. doi:10.1152/ajpheart.00883.2005
66. Wray DW, Uberoi A, Lawrenson L, Richardson RS. Heterogeneous limb vascular responsiveness to shear stimuli during dynamic exercise in humans. J Appl Physiol (1985) 99: 81-86, 2005. doi:10.1152/japplphysiol. 01285.2004
67. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988. doi:10.1038/332411a0.